Expression of FGF8, FGF18, and FGFR4 in Gastroesophageal Adenocarcinomas

Even though distinctive advances in the field of esophageal cancer therapy have occurred over the last few years, patients’ survival rates remain poor. FGF8, FGF18, and FGFR4 have been identified as promising biomarkers in a number of cancers; however no data exist on expression of FGF8, FGF18, and...

Descripción completa

Detalles Bibliográficos
Autores principales: Jomrich, Gerd, Hudec, Xenia, Harpain, Felix, Winkler, Daniel, Timelthaler, Gerald, Mohr, Thomas, Marian, Brigitte, Schoppmann, Sebastian F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6770911/
https://www.ncbi.nlm.nih.gov/pubmed/31527546
http://dx.doi.org/10.3390/cells8091092

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6770911/
https://www.ncbi.nlm.nih.gov/pubmed/31527546
http://dx.doi.org/10.3390/cells8091092

Ejemplares similares